MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 5274-5280

  Wang, Li ^a   Wang, Yan Ming ^a   Xu, Song ^a   Wang, Wei Guo ^a   Chen, Yang ^a   Mao, Jing Yu ^a   Tian, Bo Le ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Chemoresistance; Hepatocellular carcinoma; microRNA; microRNA 215; Proliferation

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DIHYDROFOLATE REDUCTASE; DOXORUBICIN; MESSENGER RNA; MICRORNA; MICRORNA 215; PROTEIN; PROTEIN P21; PROTEIN P53; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; MIRN215 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RESISTANCE; CANCER TISSUE; CELL PROLIFERATION; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEP3B CELL LINE; HEPATOCELLULAR CARCINOMA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PROTEIN EXPRESSION; UPREGULATION; APOPTOSIS; CELL SURVIVAL; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; ONCOGENE PROTEIN P21(RAS); RNA INTERFERENCE; TETRAHYDROFOLATE DEHYDROGENASE; THYMIDYLATE SYNTHASE; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84940531876     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4012     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Aravalli RN, Steer CJ and Cressman EN: Molecular mechanisms of hepatocellular carcinoma. Hepatology 48: 2047-2063, 2008.
3. Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet 362: 1907-1917, 2003.
4. Shaw JJ and Shah SA: Rising incidence and demographics of hepatocellular carcinoma in the USA: What does it mean? Expert Rev Gastroenterol Hepatol 5: 365-370, 2011.
5. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, Khan SA, Elliott P and Thomas HC: Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 48: 816-820, 2001.
6. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
7. Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
8. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
9. Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F and Ochiya T: Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem 288: 10849-10859, 2013.
10. Allen K E and Weiss GJ: Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther 9: 3126-3136, 2010.
11. Ma J, Dong C and Ji C: MicroRNA and drug resistance. Cancer Gene Ther 17: 523-531, 2010.
12. Sarkar FH, Li Y, Wang Z, Kong D and Ali S: Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat 13: 57-66, 2010.
13. Zheng T, Wang J, Chen X and Liu L: Role of microRNA in anticancer drug resistance. Int J Cancer 126: 2-10, 2010.
14. Song B, Wang Y, Titmus MA, Botchkina G, Formentini A, Kornmann M and Ju J: Molecular mechanism of chemore-sistance by miR-215 in osteosarcoma and colon cancer cells. Mol Cancer 9: 96-105, 2010.
15. Karaayvaz M, Pal T, Song B, Zhang C, Georgakopoulos P, Mehmood S, Burke S, Shroyer K and Ju J: Prognostic significance of miR-215 in colon cancer. Clin Colorectal Cancer 10: 340-347, 2011.
16. White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, et al: miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. Br J Cancer 105: 1741-1749, 2011.
17. Ivan C, Hu W, Bottsford-Miller J, et al: Comprehensive epigenetic analysis of Notch pathway in high-grade serous ovarian cancer. Gynecol Oncol 128: 506-511, 2013.
18. Mu J, Pang Q, Guo YH, Chen JG, Zeng W, Huang YJ, Zhang J and Feng B: Functional implications of microRNA-215 in TGF-β1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1. PLoS One 8: e58622, 2013.
19. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al: Real-time quantifcation of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179, 2005
20. Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY and Chen CJ: Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinasesand AKT. Eur J Pharmacol 563: 49-60, 2007.
21. Chehrehasa F, Meedeniya AC, Dwyer P, Abrahamsen G and Mackay-Sim A: EdU, a new thymidine analogue for labelling proliferating cells in the nervous system. J Neurosci Methods 177: 122-130, 2009
22. Wu QP, Xie YZ, Deng Z, Li XM, Yang W, Jiao CW, Fang L, Li SZ, Pan HH, Yee AJ, Lee DY, Li C, Zhang Z, Guo J and Yang BB: Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-mediated tumor cells onchemore-sistance. PLoS One 7: e44579, 2012.
23. Park YT, Jeong JY, Lee MJ, Kim KI, Kim TH, Kwon YD, Lee C, Kim OJ and An HJ: MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. J Ovarian Res 6: 18, 2013.
24. Robin TP, Smith A, McKinsey E, Reaves L, Jedlicka P and Ford HL: EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. Mol Cancer Res 10: 1098-1108, 2012.
25. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M: Effects of miR-34a on cell growth and chemo-resistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 377: 114-119, 2008.
26. Huang JY, Cui SY, Chen YT, Song HZ, Huang GC, Feng B, Sun M, De W, Wang R and Chen LB: MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistanceof lung adenocarcinoma cells via regulating Bcl-2/Bax expression. PLoS One 8: e72615, 2013.